Clinical trials
Active, not recruiting Observational Atherosclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 2 |
| Medical University Innsbruck | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Novartis Pharmaceuticals | 2 |
| Oslo University Hospital | 2 |
| Amgen | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 1 |
| Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 1 |
| Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 28 |
| Cardiovascular Diseases | 12 |
| Coronary Artery Disease | 7 |
| Heart Diseases | 6 |
| Coronary Disease | 5 |
| Stroke | 5 |
| Diabetes Mellitus | 3 |
| Heart Failure | 3 |
| Hypertension | 3 |
| Myocardial Infarction | 3 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.